The Patient Journey Now Starts Before the Click

Summary

AI search is starting to sit in front of the pharma website. A patient may ask about symptoms, treatment options, side effects, doctor questions, or cost before ever reaching a brand page.

That does not mean brands need to publish more pages. It means the content they already publish needs to match the questions patients actually bring into those moments.

Key Insights

There is a real evidence base behind this shift. Google says AI Overviews and AI Mode are part of Search, that standard SEO fundamentals still apply, and that generative AI features use content from Google’s Search index through grounding techniques like retrieval-augmented generation. Google has also started rolling out Search Console reporting for generative AI visibility. This is becoming a measurable search surface, not just a prediction.

There is also early evidence that AI summaries can change click behavior. Pew Research Center found that Google users were less likely to click traditional result links when an AI summary appeared. The takeaway is not that websites stop mattering. It is that a website may shape the answer before it gets the visit.

AI creates a new touchpoint before the website visit. A brand’s content may shape the answer even if the patient never clicks, which means the influence may not show up in analytics. If the approved content is hard to find or too internally written, the AI system may use clearer third-party sources instead.

So the work is not “more content.” It is better coverage of the real questions patients ask along the way. Condition education, safety explainers, doctor discussion guides, caregiver resources, access information, and Medication Guide pathways should line up with the moments when patients need them.

Patients do not ask questions in brand architecture. They ask in life architecture: “Is this normal?” “What should I ask my doctor?” “Can I afford this?” “What are the serious side effects?” Pharma content needs to connect those questions to approved answers, safety context, and a reasonable next step.

Takeaway

The patient journey is starting before the click. Pharma brands will not own that moment, but they can show up better inside it by making the right approved content easier for AI systems to find, understand, and represent accurately.